National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

HIV/AIDS
 Understanding
 Research
  Research Program
  Basic Research
  Epidemiology
  Prevention
  Therapeutics
  Vaccines
   Introduction and Goals
   Research Activities
   Resources for Researchers
   Funding
   Meetings
   Reports and Articles
   Advisory and Working Groups
   Clinical Trials
   Considerations Papers
   Education and Outreach
  Clinical Research
  Advisory Groups and Committees
  Partners and Collaborators
  Funding Opportunities
  Scientific Meetings, Workshops and Events


HIV/AIDS

Simian Vaccine Evaluation Units (SVEU) Abstracts 

 

Advanced BioScience Laboratories

Kensington, MD
Dr. Phillip Markham
HIV vaccine studies conducted by this contract involve:

  • Evaluation of the breadth of immune responses generated by consensus CON-S envelope vaccines compared to single clade B  envelope vaccines.
  • Evaluation of Alphavirus virus-like replicon particle (VRP)/HIV vaccines.
  • Evaluation of immunogenicity of measles virus vector/HIV vaccines;   immunogenicity and efficacy of measles virus vector/SIV vaccines.
  • Assessment of immunogenicity of HIV-1 gp41 peptide-containing   virosomes.

Bioqual

Rockville, MD
Dr. Mark Lewis
Some of the pre-clinical HIV vaccine studies performed by this contract are:

  • Evaluation of immunogenicity and efficacy of DNA/SIV vaccines +/- IL- 12, IL-15, or RANTES DNA delivered by intramuscular electroporation
  • Evaluation of the breadth of neutralizing antibodies induced by   immunization with HIV-1 R2 gp140 protein in GSK AS01B adjuvant.

University of Washington

Seattle, WA
Dr. David Anderson
HIV vaccine studies conducted by this contract:

  • Evaluation of HIV Tat protein vaccine and adenovirus-tat vaccine efficacy in NHP
  • Evaluation of replicating adenovirus vector vaccines in the SHIV   challenge model
  • Determination of protective efficacy of glycan-modified Env vaccine  against heterologous SHIV challenge

back to top

Highlights

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research—Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009—Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009—Sept. 25, 2009

See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News

  • Highlights

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research—Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009—Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009—Sept. 25, 2009

    See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News